Xbrane Biopharma : Xlucane™ meets the primary endpoint in the pivotal Phase III trial with ...

Retrieved on: 2021-06-27 20:37:30

Tags for this article:

Click the tags to see associated articles and topics

Xbrane Biopharma : Xlucane™ meets the primary endpoint in the pivotal Phase III trial with .... View article details on hiswai:

Excerpt

Xbrane Biopharma AB (publ) ("Xbrane" or "the Company") (Nasdaq Stockholm: XBRANE) today announces top-line results from the 6 months interim ...

Article found on: www.marketscreener.com